MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hou, Y.-T.
Right arrow Articles by Penning, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hou, Y.-T.
Right arrow Articles by Penning, T. M.

Vol. 53, Issue 3, 459-466, March 1998

Dexamethasone Regulation of the Rat 3alpha -Hydroxysteroid/Dihydrodiol Dehydrogenase Gene

Yong-Tai Hou,1 Hsueh-Kung Lin, and Trevor M. Penning

Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6084

Rat liver 3alpha -hydroxysteroid/dihydrodiol dehydrogenase (3alpha -HSD/DD), a member of the aldo-keto reductase superfamily, inactivates circulating steroid hormones and may contribute to the carcinogenicity of polycyclic aromatic hydrocarbons (PAHs) by oxidizing trans-dihydrodiols to reactive o-quinones with the concomitant generation of reactive oxygen species. The 3alpha -HSD/DD gene has been cloned, and its 5'-flanking region contains a negative response element (NRE; -797 to -498 bp) that may repress constitutive expression by binding to Oct transcription factors. Upstream from the NRE are three distal imperfect glucocorticoid response elements (GRE1, GRE2, and GRE3); in addition, a proximal imperfect GRE (GRE4) is adjacent to an Oct binding site in the NRE. When rat hepatocytes were cultured on Matrigel and exposed to dexamethasone (Dex), steady state levels of 3alpha -HSD/DD mRNA were increased 4-fold in a dose-dependent manner, yielding an EC50 value of 10 nM. Time to maximal response was 24 hr, and the effect was blocked with the anti-glucocorticoid RU486. Measurement of the half-life of 3alpha -HSD/DD mRNA, with and without Dex treatment, indicated that the increase in steady state mRNA levels was not due to increased mRNA stability. By contrast, nuclear run-off experiments using nuclei obtained from Dex-stimulated hepatocytes indicated that Dex increased transcription of the rat 3alpha -HSD/DD gene. Tandem repeats of the imperfect GRE1, GRE2, GRE3, and GRE4 were inserted into thymidine kinase-chloramphenicol acetyl-transferase vectors and cotransfected with the human glucocorticoid receptor into human hepatoma cells. On treatment with Dex, maximal trans-activation of the chloramphenicol acetyl-transferase reporter gene activity was mediated via the proximal GRE (GRE4). These data imply that GRE4 is a functional cis-element and that binding of the occupied glucocorticoid receptor to this element increases 3alpha -HSD/DD gene transcription. A model is proposed for the positive and negative regulation of the rat 3alpha -HSD/DD gene by the glucocorticoid receptor and Oct transcription factors, respectively.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. L. McCarthy, R. B. Hochberg, D. C. Labaree, and M. Centrella
3-Ketosteroid Reductase Activity and Expression by Fetal Rat Osteoblasts
J. Biol. Chem., November 23, 2007; 282(47): 34003 - 34012.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Salemi, S. Yousefi, D. Lochmatter, A. Eble, J. Deladoey, I. C. A. F. Robinson, H.-U. Simon, and P. E. Mullis
Isolated Autosomal Dominant Growth Hormone Deficiency: Stimulating Mutant GH-1 Gene Expression Drives GH-1 Splice-Site Selection, Cell Proliferation, and Apoptosis
Endocrinology, January 1, 2007; 148(1): 45 - 53.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. R. Bauman, S. Steckelbroeck, M. V. Williams, D. M. Peehl, and T. M. Penning
Identification of the Major Oxidative 3{alpha}-Hydroxysteroid Dehydrogenase in Human Prostate That Converts 5{alpha}-Androstane-3{alpha},17{beta}-diol to 5{alpha}-Dihydrotestosterone: A Potential Therapeutic Target for Androgen-Dependent Disease
Mol. Endocrinol., February 1, 2006; 20(2): 444 - 458.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C.-F. Hung and T. M. Penning
Members of the Nuclear Factor 1 Transcription Factor Family Regulate Rat 3{alpha}-Hydroxysteroid/Dihydrodiol Dehydrogenase (3{alpha}-HSD/DD AKR1C9) Gene Expression: A Member of the Aldo-keto Reductase Superfamily
Mol. Endocrinol., October 1, 1999; 13(10): 1704 - 1717.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics